Perfluorocarbon-Loaded Polymer Beads for Stable Ultrasound Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ultrasound contrast agents for medical imaging are unsuitable for cell labeling and in vivo targeting due to their large size, instability, and potential for cell damage, limiting their effectiveness and longevity in imaging applications.
Innovation Solution
A process for preparing biocompatible beads comprising a hydrophobic polymer, polyvinylalcohol, and perfluorocarbon, with optional metal compounds, using sonication to achieve a narrow size distribution and improved yield, enabling visibility across multiple imaging modalities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If gas-filled microbubbles are used as ultrasound contrast agents, then ultrasound visibility is improved, but the agents are unstable and have short lifetime
Solution Approach 1:
The invention changes the physical state of the contrast agent from gas-filled microbubbles to liquid-filled beads containing perfluorocarbon. This parameter change transforms the unstable gas phase into a stable liquid phase, extending the agent's lifetime from seconds/minutes to days/weeks while maintaining ultrasound visibility through the perfluorocarbon's acoustic properties.
Solution Approach 2:
The invention creates composite beads comprising a biocompatible hydrophobic polymer matrix combined with perfluorocarbon liquid and optionally metal compounds. This composite structure provides both ultrasound contrast (from perfluorocarbon) and MRI contrast (from metal compounds like gadolinium), while the polymer matrix ensures structural stability and biocompatibility.
2Illumination intensity
If gas-filled microbubbles are used as contrast agents, then ultrasound imaging is enhanced, but cell damage may occur
Solution Approach 1:
The invention changes the contrast agent from gas-filled to liquid-filled, eliminating the bursting mechanism that causes cell damage. The liquid perfluorocarbon remains stable within the bead structure, providing continuous ultrasound contrast without the mechanical disruption that occurs with gas bubble collapse.
Solution Approach 2:
The invention replaces the short-lived gas-filled microbubbles (lasting seconds to minutes) with long-lived liquid-filled beads that remain stable for days to weeks. This extends the useful lifetime of the contrast agent while eliminating the harmful bursting effect of short-lived gas bubbles.
3Illumination intensity
If large-sized microbubbles are used for ultrasound imaging, then contrast enhancement is achieved, but the agents cannot leave the circulation for targeting
Solution Approach 1:
The invention segments the contrast agent into small bead sizes (50-500 nm) that can pass through blood vessel walls and reach target tissues. This size reduction allows the beads to leave the circulation and accumulate at disease sites such as tumors, providing both contrast enhancement and targeted imaging capabilities.
Solution Approach 2:
The invention changes the size parameter of the contrast agent from large microbubbles (1000-10000 nm) to small beads (50-500 nm). This parameter change enables the beads to extravasate from blood vessels and reach target tissues, providing versatility for both blood pool imaging and targeted imaging applications.
4Productivity
If rapid addition of first liquid mixture to PVA solution is performed, then bead formation efficiency is improved, but mixing uniformity may be compromised
Solution Approach 1:
The invention applies ultrasonic vibration during the mixing process to achieve both rapid mixing and uniform bead formation. The ultrasonic energy promotes cavitation and micro-turbulence, ensuring homogeneous distribution of components while maintaining narrow size distribution, thus resolving the contradiction between speed and uniformity.
Solution Approach 2:
The invention uses periodic ultrasonic pulses during the bead formation process to maintain both high productivity and uniformity. The periodic vibration creates consistent mixing conditions that promote uniform nucleation and growth of beads, even during rapid addition of the first liquid mixture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting beads provide enhanced visibility in various imaging techniques, including ultrasound, MRI, and fluorescence imaging, with stability for repeated use and improved targeting capabilities, suitable for cell labeling and drug delivery.
Implementation Method 1
adding the first liquid mixture to an aqueous solution containing polyvinylalcohol (PVA) under sonication
Implementation Method 2
maintaining the sonication of the second liquid mixture while cooling
Implementation Method 3
maintaining the sonication of the second liquid mixture while cooling
Implementation Method 4
evaporating the polar solvent from the second liquid mixture to obtain a suspension of beads
Implementation Method 5
freezing-drying the water suspension to obtain the beads
Data Source
AI summary
A process for the preparation of beads including a biocompatible hydrophobic polymer, a perfluorocarbon, polyvinylalcohol and optionally a metal compound, including the steps of: adding the perfluorocarbon and optionally the metal compound to a solution of the biocompatible hydrophobic polymer in a polar solvent to provide a first liquid mixture, adding the first liquid mixture to an aqueous solution of a biocompatible surfactant including polyvinylalcohol under sonication to obtain a second liquid mixture, a) maintaining the sonication of the second liquid mixture while cooling, b) evaporating the polar solvent from the second liquid mixture to obtain a suspension of beads including the biocompatible hydrophobic polymer, the perfluorocarbon and optionally the metal compound, c) separating the beads from the suspension and preparing a water suspension of the beads and d) freeze-drying the water suspension to obtain the beads, wherein the addition of the first liquid mixture to the biocompatible surfactant in step b) is performed within a period of at most 10 seconds, wherein the sonication in step b) and the sonication in step c) are performed directly into the liquid mixtures by for example a probe or flow sonicator at an amplitude of at least 120 μm for 0.01-10 minutes and wherein the weight ratio of the biocompatible surfactant to the biocompatible hydrophobic polymer is at least 3:1. Beads having close F—H2O interactions, which are suitable for imaging purposes.